The Cost of Cancer and How Healthcare Providers Can Help Mitigate Financial Toxicity
A close-up look at the cost of cancer care, current legislative actions, and tools clinicians can use to help ease patients’ financial burden.
Financial Toxicity
Mitigating Financial Toxicity
A significant part of coping with cancer is the cost of treatment, especially co-pays and deductibles, but the financial impact of cancer can be more than just medical costs. Navigators should be aware of these financial issues that may affect their patients.
Financial Navigation Improves Financial Toxicity for Patients and Oncology Care Model Compliance for Cancer Centers
Significant improvements in financial toxicity was achieved when a dedicated financial navigator role was implemented at a major cancer center.
The Cost of Cancer Treatment: Financial Toxicity in Acute Leukemia
What is the role of the clinician in managing financial toxicity?
Doctors Aware of Patient Difficulties Affording Medical Care
Three-quarters of doctors surveyed say they consider out-of-pocket costs when making clinical decisions.
Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
In a randomized study, researchers sought to determine the effect of a nurse-led care program on unscheduled hospital visits and admissions and cost for patients with breast cancer undergoing outpatient chemotherapy.
Financial Toxicity Discussions an Unmet Need for Breast Cancer Patients
Survey responses revealed that clinicians and patients do not agree on whether discussions regarding the impact of treatment on employment and/or financial status occur or are helpful.
The Health Care Mortgage: Understanding the Complexities of Financial Toxicity
Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient’s ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
Financial Toxicity Impacts Prescription Drug Adherence in Patients With Cancer and Survivors
Researchers found that non-elderly cancer survivors may be particularly vulnerable to financial toxicity.
Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
Patients with multiple myeloma may be vulnerable to financial toxicity, even those with health insurance and those who make more than $100,000 a year, due to the higher use of novel therapeutics and extended duration of myeloma treatment.
